Low-density lipoprotein-cholesterol lowering effect of a nutraceutical regimen with or without ezetimibe in hypercholesterolaemic patients with statin intolerance

BACKGROUND: Statins are the most widely prescribed medication to lower low-density lipoprotein cholesterol (LDL-c). However, a significant portion of patients are unable to tolerate them due to side effects, most commonly muscle related. Nutraceuticals, natural plant derivatives with lipid-lowering...

Descripción completa

Detalles Bibliográficos
Autores principales: Ward, Natalie C., Reid, Christopher M., Watts, Gerald F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732015/
https://www.ncbi.nlm.nih.gov/pubmed/36505352
http://dx.doi.org/10.3389/fcvm.2022.1060252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732015/
https://www.ncbi.nlm.nih.gov/pubmed/36505352
http://dx.doi.org/10.3389/fcvm.2022.1060252

Ejemplares similares